Yeda Research and Development Company Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Yeda Research and Development Company Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013549
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yeda Research and Development Company Ltd (Yeda), a subsidiary of Weizmann Institute of Science is a technology transfer company that provides research and science education. The company identifies and assesses research projects with commercial potential, protects the intellectual property of the institute and its scientists, licenses the institute’s inventions and technologies to industry, and channels funding from industry to research projects. It offers services to various industries such as biotechnology, pharmaceuticals and diagnostics, bioinformatics, proteomics, agriculture and plant genetics, biomatics and system biology, medical devices, renewable energy, bio-fuels, cleantech and environmental sciences, bio-fuels, chemistry and nanotechnology, physics and electro-optics, and mathematics and computer science. Yeda is headquartered in Rehovot, Israel.

Yeda Research and Development Company Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Yeda Research and Development Company Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Galmed Pharma Enters into Research Agreement with Yeda Research and Development 12
XL-protein Enters into Collaboration Agreement with Yeda Research 13
Immune Pharma Enters Into Co-Development Agreement With Yeda Research 14
Abbott Labs Enters Into Co-Development Agreement With Yeda Research 15
Licensing Agreements 16
TxCell Exercises Option for Licensing Agreement with Yeda Research and Development 16
XTL Biopharma Amends Licensing Agreement with Yeda Research for hCDR1 17
Cell Source Enters into Licensing Agreement with Yeda Research and Development 19
Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development 20
Tikcro Technologies Amends its Research and Licensing Agreement with Yeda Research and Development 21
Soligenix Enters into Licensing Agreement with New York University and Yeda Research and Development 22
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 23
miCure Therapeutics Enters into Licensing Agreement with Yeda Research 24
PROLOR Biotech Enters Into Licensing Agreement With Yeda Research 25
Yeda Research and Development Company Ltd – Key Competitors 26
Yeda Research and Development Company Ltd – Key Employees 27
Yeda Research and Development Company Ltd – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Product News 29
Jan 23, 2017: RondinX Expands its Microbiome Computational Platform for Drug Development with a Unified Reference Range of Bacterial Dynamics Based on Database of 1,400 Healthy Individuals 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Yeda Research and Development Company Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Yeda Research and Development Company Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Yeda Research and Development Company Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Galmed Pharma Enters into Research Agreement with Yeda Research and Development 12
XL-protein Enters into Collaboration Agreement with Yeda Research 13
Immune Pharma Enters Into Co-Development Agreement With Yeda Research 14
Abbott Labs Enters Into Co-Development Agreement With Yeda Research 15
TxCell Exercises Option for Licensing Agreement with Yeda Research and Development 16
XTL Biopharma Amends Licensing Agreement with Yeda Research for hCDR1 17
Cell Source Enters into Licensing Agreement with Yeda Research and Development 19
Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development 20
Tikcro Technologies Amends its Research and Licensing Agreement with Yeda Research and Development 21
Soligenix Enters into Licensing Agreement with New York University and Yeda Research and Development 22
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 23
miCure Therapeutics Enters into Licensing Agreement with Yeda Research 24
PROLOR Biotech Enters Into Licensing Agreement With Yeda Research 25
Yeda Research and Development Company Ltd, Key Competitors 26
Yeda Research and Development Company Ltd, Key Employees 27

★海外企業調査レポート[Yeda Research and Development Company Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Emirates Group:企業の戦略・SWOT・財務分析
    The Emirates Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Yamana Gold Inc.
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • IntegraGen SA (ALINT):企業の財務・戦略的SWOT分析
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • Tennessee Valley Authority:発電所・企業SWOT分析
    Tennessee Valley Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Gulf Power Co:発電所・企業SWOT分析
    Gulf Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Alfa SAB de CV (ALFAA):企業の財務・戦略的SWOT分析
    Alfa SAB de CV (ALFAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • OCI Co Ltd (010060):電力:M&Aディール及び事業提携情報
    Summary OCI Co Ltd (OCI) is a green energy and chemical company. It manufactures and sells a wide range of inorganic chemicals, coal and petrochemicals, and fine chemicals. The company’s product portfolio includes toluene di-isocyanate (TDI), hydrogen peroxide, carbon black, pitch, sodium percarbona …
  • Hoverink Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Hoverink Biotechnologies Inc (Hoverink) formerly Hoverink International Holdings Inc, is a preclinical biopharmaceutical company that discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and on …
  • Macmahon Holdings Ltd:企業の戦略・SWOT・財務分析
    Macmahon Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Macmahon Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hanger, Inc. (HNGR):企業の財務・戦略的SWOT分析
    Hanger, Inc. (HNGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • C&D Technologies Inc:企業の戦略的SWOT分析
    C&D Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • adidas AG (ADS):企業の財務・戦略的SWOT分析
    adidas AG (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Canara Bank:企業の戦略・SWOT・財務分析
    Canara Bank - Strategy, SWOT and Corporate Finance Report Summary Canara Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CITIC Securities Company Limited:企業の戦略・SWOT・財務分析
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Max Hamburgerrestauranger AB:戦略・SWOT・企業財務分析
    Max Hamburgerrestauranger AB - Strategy, SWOT and Corporate Finance Report Summary Max Hamburgerrestauranger AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Singapore Airlines Ltd:企業の戦略・SWOT・財務分析
    Singapore Airlines Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Airlines Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Immunomedics Inc (IMMU):企業の財務・戦略的SWOT分析
    Immunomedics Inc (IMMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cegedim SA (CGM):企業の財務・戦略的SWOT分析
    Summary Cegedim SA (Cegedim) is a technology company that offers healthcare technical services. The company offers solutions to facilitate business and medical operations. It offers health and preventive health management software used in management of individual and collective health and preventive …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • Formation Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Formation Biologics Inc (Formation Biologics), formerly AvidBiologics Inc is a clinical stage pharmaceutical company that develops biologics and antibody-drug conjugates (ADCs) with selective anti-tumor properties for the treatment of cancer and rare diseases. The company’s pipeline product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆